Crypto · News reference
Stocks slid as the 10-year Treasury yield hit a 19-year high on blowout PMI data; cybersecurity stocks bucked the selloff.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
UPS faces headwinds from elevated fuel costs, Amazon's new supply chain services, and declining e-commerce demand, which could lead to missed earnings estimates in Q3 2026. However, the stock's high dividend yield and market expectations of a miss may position it for recovery if the company merely meets expectations. The dividend sustainability remains a concern despite the potential value opportunity.
https://www.bloomberg.com/news/articles/2026-10-14/anthropic-revenue-jumps-to-16-8-billion-in-quarter-before-ipo
Jim Cramer endorsed CoreWeave as the only AI neocloud he trusts, but the stock plunged 15% the next day after venture capitalist Chamath Palihapitiya highlighted concerns about the company's soaring debt levels. CoreWeave faces significant financial risks with $51.6 billion in total debt obligations and projected negative free cash flow of $25-28 billion annually through 2028, raising questions about whether strong customer demand can offset the company's aggressive borrowing strategy.
Microsoft unveiled its Maia 300 AI chip, claiming 40% better token processing per megawatt than GPUs. Rather than competing on raw power where Nvidia dominates, Microsoft is targeting cost efficiency for AI inference workloads. The chip signals a shift in the AI industry from pure performance competition toward optimizing economics and cost-per-token delivery, though Nvidia's high-end processors remain critical to Microsoft's AI strategy.
Arrowhead Pharma shares Phase 1/2a data for ARO-MAPT, showing up to 85% tau reduction in central nervous system Alzheimer's disease trial.
Arrowhead’s TRiM™ platform achieves clinical validation for delivery of siRNA that crosses the blood-brain barrier after subcutaneous injectionARO-MAPT demonstrates mean cerebrospinal fluid total tau reduction of 73% on